Cover Image

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833

The effect of P-glycoprotein inhibition on the uptake of the HIV type 1 protease inhibitor saquinavir into brain capillary endothelial cells was studied using porcine primary brain capillary endothelial cell monolayers as an in vitro test system. As confirmed by polymerase chain reaction and Western...

Full description

Saved in:
Bibliographic Details
Main Authors: Drewe, Jürgen (Author) , Gutmann, Heike (Author) , Fricker, Gert (Author) , Török, Michael (Author) , Beglinger, Christoph (Author) , Huwyler, Jörg (Author)
Format: Article (Journal)
Language:English
Published: 1999
In: Biochemical pharmacology
Year: 1999, Volume: 57, Issue: 10, Pages: 1147-1152
ISSN:1873-2968
DOI:10.1016/S0006-2952(99)00026-X
Online Access:Verlag, kostenfrei registrierungspflichtig, Volltext: http://dx.doi.org/10.1016/S0006-2952(99)00026-X
Verlag, kostenfrei registrierungspflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S000629529900026X
Get full text
Author Notes:Jürgen Drewe, Heike Gutmann, Gert Fricker, Michael Török, Christoph Beglinger, and Jörg Huwyler

MARC

LEADER 00000caa a2200000 c 4500
001 1556980795
003 DE-627
005 20230426153700.0
007 cr uuu---uuuuu
008 170426s1999 xx |||||o 00| ||eng c
024 7 |a 10.1016/S0006-2952(99)00026-X  |2 doi 
035 |a (DE-627)1556980795 
035 |a (DE-576)486980790 
035 |a (DE-599)BSZ486980790 
035 |a (OCoLC)1340973294 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Drewe, Jürgen  |e VerfasserIn  |0 (DE-588)1130727483  |0 (DE-627)885089022  |0 (DE-576)486975401  |4 aut 
245 1 0 |a HIV protease inhibitor ritonavir  |b a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833  |c Jürgen Drewe, Heike Gutmann, Gert Fricker, Michael Török, Christoph Beglinger, and Jörg Huwyler 
264 1 |c 1999 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.04.2017 
520 |a The effect of P-glycoprotein inhibition on the uptake of the HIV type 1 protease inhibitor saquinavir into brain capillary endothelial cells was studied using porcine primary brain capillary endothelial cell monolayers as an in vitro test system. As confirmed by polymerase chain reaction and Western blot analysis, this system functionally expressed class I P-glycoprotein (pgp1A). P-Glycoprotein isoforms pgp1B or pgp1D could not be detected. The uptake of saquinavir into endothelial cells could be described as the result of a diffusional term of uptake and an oppositely directed saturable extrusion process. Net uptake of saquinavir into cultured brain endothelial cells could be increased significantly up to 2-fold by SDZ PSC 833 in a dose-dependent manner, with an ic50 of 1.13 μM. In addition, the HIV protease inhibitor ritonavir inhibited p-glycoprotein-mediated extrusion of saquinavir with an ic50 of 0.2 μM, indicating a high affinity of ritonavir for p-glycoprotein. In conclusion, we showed that the HIV protease inhibitor ritonavir is a more potent inhibitor of P-glycoprotein than the multidrug resistance (MDR)-reversing agent SDZ PSC 833. The inclusion of this drug in combination regimens may greatly facilitate brain uptake of HIV protease inhibitors, which is especially important in patients suffering from AIDS dementia complex. 
650 4 |a AIDS 
650 4 |a AIDS dementia complex 
650 4 |a blood-brain barrier 
650 4 |a HIV protease inhibitors 
650 4 |a indinavir 
650 4 |a nelfinavir 
650 4 |a P-glycoprotein 
650 4 |a ritonavir 
650 4 |a saquinavir 
650 4 |a SDZ PSC 833 
700 1 |a Gutmann, Heike  |e VerfasserIn  |0 (DE-588)113072946X  |0 (DE-627)885093720  |0 (DE-576)486979202  |4 aut 
700 1 |a Fricker, Gert  |d 1956-  |e VerfasserIn  |0 (DE-588)1042227675  |0 (DE-627)768469465  |0 (DE-576)393783464  |4 aut 
700 1 |a Török, Michael  |e VerfasserIn  |0 (DE-588)1130596443  |0 (DE-627)884810216  |0 (DE-576)486854345  |4 aut 
700 1 |a Beglinger, Christoph  |d 1950-  |e VerfasserIn  |0 (DE-588)113146647  |0 (DE-627)517879751  |0 (DE-576)28975349X  |4 aut 
700 1 |a Huwyler, Jörg  |e VerfasserIn  |0 (DE-588)1130682978  |0 (DE-627)884877876  |0 (DE-576)486914801  |4 aut 
773 0 8 |i Enthalten in  |t Biochemical pharmacology  |d Amsterdam [u.a.] : Elsevier Science, 1958  |g 57(1999), 10, Seite 1147-1152  |h Online-Ressource  |w (DE-627)30631777X  |w (DE-600)1496199-4  |w (DE-576)081952929  |x 1873-2968  |7 nnas  |a HIV protease inhibitor ritonavir a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833 
773 1 8 |g volume:57  |g year:1999  |g number:10  |g pages:1147-1152  |g extent:6  |a HIV protease inhibitor ritonavir a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833 
856 4 0 |u http://dx.doi.org/10.1016/S0006-2952(99)00026-X  |x Verlag  |z kostenfrei registrierungspflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S000629529900026X  |x Verlag  |z kostenfrei registrierungspflichtig  |3 Volltext 
951 |a AR 
992 |a 20170426 
993 |a Article 
994 |a 1999 
998 |g 1042227675  |a Fricker, Gert  |m 1042227675:Fricker, Gert  |d 170000  |d 170200  |d 160000  |d 160100  |e 170000PF1042227675  |e 170200PF1042227675  |e 160000PF1042227675  |e 160100PF1042227675  |k 0/170000/  |k 1/170000/170200/  |k 0/160000/  |k 1/160000/160100/  |p 3 
999 |a KXP-PPN1556980795  |e 2966861703 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"HIV protease inhibitor ritonavir","subtitle":"a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833","title_sort":"HIV protease inhibitor ritonavir"}],"person":[{"family":"Drewe","display":"Drewe, Jürgen","role":"aut","given":"Jürgen"},{"given":"Heike","role":"aut","display":"Gutmann, Heike","family":"Gutmann"},{"given":"Gert","role":"aut","display":"Fricker, Gert","family":"Fricker"},{"family":"Török","role":"aut","given":"Michael","display":"Török, Michael"},{"family":"Beglinger","given":"Christoph","role":"aut","display":"Beglinger, Christoph"},{"family":"Huwyler","display":"Huwyler, Jörg","given":"Jörg","role":"aut"}],"name":{"displayForm":["Jürgen Drewe, Heike Gutmann, Gert Fricker, Michael Török, Christoph Beglinger, and Jörg Huwyler"]},"note":["Gesehen am 26.04.2017"],"relHost":[{"pubHistory":["1.1958 -"],"title":[{"title_sort":"Biochemical pharmacology","title":"Biochemical pharmacology"}],"part":{"year":"1999","text":"57(1999), 10, Seite 1147-1152","volume":"57","pages":"1147-1152","extent":"6","issue":"10"},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1958","dateIssuedDisp":"1958-","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]"}],"recId":"30631777X","id":{"eki":["30631777X"],"zdb":["1496199-4"],"issn":["1873-2968"]},"disp":"HIV protease inhibitor ritonavir a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833Biochemical pharmacology","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 21.02.20"]}],"physDesc":[{"extent":"6 S."}],"id":{"doi":["10.1016/S0006-2952(99)00026-X"],"eki":["1556980795"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"1999"}],"recId":"1556980795"} 
SRT |a DREWEJUERGHIVPROTEAS1999 

Similar Items